Free Trial

Beauty Health (SKIN) Competitors

Beauty Health logo
$1.42 +0.03 (+2.16%)
(As of 11/22/2024 ET)

SKIN vs. ME, EMBK, HLLY, BFLY, IRMD, KIDS, AXGN, SIBN, TMCI, and SMLR

Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include 23andMe (ME), Embark Technology (EMBK), Holley (HLLY), Butterfly Network (BFLY), Iradimed (IRMD), OrthoPediatrics (KIDS), AxoGen (AXGN), SI-BONE (SIBN), Treace Medical Concepts (TMCI), and Semler Scientific (SMLR).

Beauty Health vs.

23andMe (NASDAQ:ME) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings.

23andMe presently has a consensus target price of $9.40, indicating a potential upside of 202.25%. Beauty Health has a consensus target price of $2.55, indicating a potential upside of 79.58%. Given 23andMe's higher possible upside, research analysts plainly believe 23andMe is more favorable than Beauty Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
23andMe
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Beauty Health
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Beauty Health has higher revenue and earnings than 23andMe. Beauty Health is trading at a lower price-to-earnings ratio than 23andMe, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
23andMe$219.64M0.35-$666.70M-$25.32-0.12
Beauty Health$398M0.44-$100.12M-$0.42-3.38

In the previous week, Beauty Health had 4 more articles in the media than 23andMe. MarketBeat recorded 15 mentions for Beauty Health and 11 mentions for 23andMe. Beauty Health's average media sentiment score of 1.14 beat 23andMe's score of -0.41 indicating that Beauty Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
23andMe
0 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Neutral
Beauty Health
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

36.1% of 23andMe shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 26.3% of 23andMe shares are held by insiders. Comparatively, 41.0% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Beauty Health received 28 more outperform votes than 23andMe when rated by MarketBeat users. However, 60.00% of users gave 23andMe an outperform vote while only 45.98% of users gave Beauty Health an outperform vote.

CompanyUnderperformOutperform
23andMeOutperform Votes
12
60.00%
Underperform Votes
8
40.00%
Beauty HealthOutperform Votes
40
45.98%
Underperform Votes
47
54.02%

23andMe has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500.

Beauty Health has a net margin of -8.11% compared to 23andMe's net margin of -318.39%. Beauty Health's return on equity of -44.83% beat 23andMe's return on equity.

Company Net Margins Return on Equity Return on Assets
23andMe-318.39% -129.98% -62.37%
Beauty Health -8.11%-44.83%-3.54%

Summary

Beauty Health beats 23andMe on 14 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SKIN vs. The Competition

MetricBeauty HealthSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$176.11M$4.51B$5.38B$8.84B
Dividend YieldN/A36.80%5.14%4.09%
P/E Ratio-3.3826.00105.9717.81
Price / Sales0.4446.931,247.00162.50
Price / CashN/A53.5740.3436.29
Price / Book2.965.927.086.50
Net Income-$100.12M$13.99M$119.65M$226.10M
7 Day Performance-7.19%3.02%2.15%3.98%
1 Month Performance-14.97%2.70%-3.13%3.78%
1 Year Performance-36.18%46.86%33.79%29.31%

Beauty Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SKIN
Beauty Health
2.962 of 5 stars
$1.42
+2.2%
$2.55
+79.6%
-36.2%$176.11M$398M-3.381,030Positive News
ME
23andMe
1.3588 of 5 stars
$3.08
-4.6%
$9.40
+205.2%
-82.3%$75.49M$219.64M-0.12770
EMBK
Embark Technology
N/A$2.88
flat
N/AN/A$69.26MN/A-0.37329
HLLY
Holley
3.6889 of 5 stars
$2.84
+3.6%
$6.63
+133.3%
-29.3%$340.23M$659.70M21.081,633
BFLY
Butterfly Network
0.7704 of 5 stars
$3.20
-2.7%
$3.00
-6.3%
+217.6%$681.79M$65.90M-7.16460
IRMD
Iradimed
4.5248 of 5 stars
$53.44
+0.4%
$60.00
+12.3%
+30.5%$677.25M$71.31M36.46110
KIDS
OrthoPediatrics
4.0323 of 5 stars
$26.55
+0.3%
$40.00
+50.7%
-17.1%$642.94M$189.67M-21.51200
AXGN
AxoGen
2.7069 of 5 stars
$13.03
-0.5%
$15.00
+15.1%
+126.1%$573.42M$180.86M-40.94426
SIBN
SI-BONE
4.2817 of 5 stars
$12.28
-0.1%
$23.00
+87.3%
-29.9%$515.02M$138.89M-13.38350Analyst Forecast
Insider Trade
TMCI
Treace Medical Concepts
0.9925 of 5 stars
$7.88
-0.8%
$7.40
-6.1%
-9.3%$490.92M$187.12M-8.02250
SMLR
Semler Scientific
1.1109 of 5 stars
$62.00
-6.7%
N/A+72.3%$450.74M$68.18M30.0392News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:SKIN) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners